{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:01:15Z","timestamp":1790348475576,"version":"4.1.0"},"reference-count":58,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["movementdisorders.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cognitive measures in Huntington's disease (HD) play an important role in clinical trial endpoint strategies; however, clinically meaningful change in these measures is difficult to interpret. Cognition is a key predictor of function, and measures of functional capacity can be used as anchors to determine minimally clinically important differences (MCID) on measures of cognition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to estimate the MCID for cognitive measures commonly used in clinical research using two functional capacity measures as anchors. We also compared MCID estimates made using functional capacity as an anchor to those made using the health impairment measured on the 12\u2010item short\u2010form health survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data from the Enroll\u2010HD study using participants with Stage 2 and Stage 3 HD using the HD Integrated Staging System. We estimated MCID scores using linear mixed\u2010effects regression at 12\u2010, 24\u2010, and 36\u2010months using the smallest measurable change in functional capacity on each measure as anchors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The amount of change in cognitive measures associated with functionally meaningful decline was larger as disease progressed and time frames increased,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;\u20090.05. MCID estimates made using measures of function as anchors were generally comparable to those made using health impairment, although those made using health impairment were generally larger at 36 months,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;\u20090.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MCID estimates differed between disease stages and over different time frames. Using measures of everyday function as anchors to estimate MCID thresholds on these measures will aid the interpretation of how cognitive change translates to important change in everyday life. \u00a9 2026 International Parkinson and Movement Disorder Society.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/mds.70185","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:30:17Z","timestamp":1770125417000},"page":"870-880","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Minimal Clinically Important Difference on Cognitive Measures for Huntington's Disease Using Function as an Anchor"],"prefix":"10.1002","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9898-8327","authenticated-orcid":false,"given":"Cali M.","family":"Roiboit","sequence":"first","affiliation":[{"name":"School of Psychological Sciences Monash University  Clayton Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7803-4679","authenticated-orcid":false,"given":"Douglas R.","family":"Langbehn","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Iowa Carver College of Medicine Psychiatry Research  Iowa City Iowa USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9637-8590","authenticated-orcid":false,"given":"Julie C.","family":"Stout","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences Monash University  Clayton Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29394"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70170-X"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26012"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011893"},{"key":"e_1_2_10_6_1","first-page":"409","article-title":"Cognitive impairment in Huntington's disease and its impact on functioning: concept elicitation and cognitive debriefing for the Huntington's disease everyday functioning (hi\u2010DEF) scale","volume":"13","author":"Petrillo J","year":"2024","journal-title":"J Huntingtons Dis"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25101"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.02.022"},{"key":"e_1_2_10_9_1","unstructured":"FDA.The Voice of the Patient: Huntington's Disease;2016.https:\/\/fda.report\/media\/96196\/The-Voice-of-the-Patient--Huntington_s-Disease.pdf+%2Autf-8%27%27The-Voice-of-the-Patient--Huntington%25E2%2580%2599s-Disease.pdf(Accessed 15 January 2023)."},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-160228"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2008.01.008"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00121-1"},{"key":"e_1_2_10_13_1","unstructured":"FDA.Patient\u2010Focused Drug Development: Incorporating Clinical Outcome Assessments Into Endpoints For Regulatory Decision\u2010Making;2023.https:\/\/www.fda.gov\/media\/166830\/download(Accessed 09 May 2023)."},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1745855208006182"},{"key":"e_1_2_10_15_1","first-page":"4S","article-title":"Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials","volume":"10","author":"Keefe RSE","year":"2013","journal-title":"Innov Clin Neurosci"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12181"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301940"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2019.30"},{"key":"e_1_2_10_19_1","unstructured":"EMA.Discussion Paper on the clinical investigation of medicines for the treatment of Alzheimer's disease and other dementias;2014.https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/discussion-paper-clinical-investigation-medicines-treatment-alzheimers-disease-other-dementias_en.pdf(Accessed 21 July 2023)."},{"key":"e_1_2_10_20_1","unstructured":"FDA.Early Alzheimer's Disease: Developing Drugs for Treatment Guidance for Industry;2018.https:\/\/www.fda.gov\/files\/drugs\/published\/Alzheimer%E2%80%99s-Disease---Developing-Drugs-for-Treatment-Guidance-for-Industy.pdf(Accessed 04 March 2024)."},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0386-7"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1179\/jmt.2008.16.4.82E"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/pzz106"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01228-7"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1714"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-023-02157-3"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2022.102"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12312"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2019.06.005"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870110204"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00120-X"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12388"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28222"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28944"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1494816"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29963"},{"key":"e_1_2_10_37_1","first-page":"270","article-title":"Longitudinal assessment of the unified Huntington's disease rating scale (UHDRS) and the UHDRS\u2010for advanced patients (UHDRS\u2010FAP) in patients with late stage Huntington's disease","volume":"26","author":"Winder JY","year":"2018","journal-title":"Eur J Neurol"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199603000-00003"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2006.00570.x"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.4085\/1062-6050-1007.22"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11804-0"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13770"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0101-60832012000500003"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.2.452"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2010.04.030"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/2047-9158-3-15"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-140115"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0000000000002871"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.02.016"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15098"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/18796397241289044"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1177\/18796397251323549"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1081\/COPD-200050508"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-013-2776-5"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23337"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-011-0215-x"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25964"},{"key":"e_1_2_10_58_1","unstructured":"EMA.Guideline on the clinical investigation of medicines for the treatment of Alzheimer's disease;2018.https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-investigation-medicines-treatment-alzheimers-disease-revision-2_en.pdf(Accessed 22 February 2023)."},{"key":"e_1_2_10_59_1","unstructured":"FDA.Alzheimer's Disease: Developing Drugs for the Treatment of Early Stage Disease;2013.https:\/\/isctm.org\/public_access\/FDAGuidance_AD_Developing_Drugs_Early_Stage_Treatment.pdf(Accessed 04 March 2024)."}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.70185","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mds.70185","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.70185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:20:10Z","timestamp":1790346010000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.70185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1002\/mds.70185"],"URL":"https:\/\/doi.org\/10.1002\/mds.70185","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"2025-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}